Halo Hospice 314 East Main, Ada, OK, 74820 | |
(580) 332-8009 |
News Archive
Cannabis Science Inc. (NASD OTCBB: CBIS) an emerging pharmaceutical cannabis company, is pleased to report that it will be featured on two broadcast radio shows beginning tomorrow with Stu Taylor and the "Equity Strategies Show". Mr. Taylor will interview Cannabis Science Inc., President & CEO, Dr. Robert Melamede Ph.D., discussing the Company's strategies with its FDA Drug approval programs, the Company's progress to date with its critical drug release programs, and future planning for subsequent drug releases through additional Federal and State government agencies.
The Food and Drug Administration (FDA) has approved a device that automatically monitors blood glucose levels and delivers insulin when appropriate, for people aged 14 years and older who have type 1 diabetes.
Autism affects 1 in 150 children today, making it more common than childhood cancer, juvenile diabetes and pediatric AIDS combined. Despite its widespread effect, autism is not well understood and there are no objective medical tests to diagnose it. Recently, University of Missouri researchers have developed a pupil response test that is 92.5 percent accurate in separating children with autism from those with typical development. In the study, MU scientists found that children with autism have slower pupil responses to light change.
Tomosynthesis imaging may improve breast cancer detection while reducing recall rates at mammographic screening, say researchers.
› Verified 1 days ago
Name | Halo Hospice |
---|---|
Location | 314 East Main, Ada, Oklahoma |
Hospice ID | 371655 |
Category | Freestanding Hospice |
Ownership Type | Proprietary - Individual |
Profit Type | FOR PROFIT |
SSA county code | 610 |
News Archive
Cannabis Science Inc. (NASD OTCBB: CBIS) an emerging pharmaceutical cannabis company, is pleased to report that it will be featured on two broadcast radio shows beginning tomorrow with Stu Taylor and the "Equity Strategies Show". Mr. Taylor will interview Cannabis Science Inc., President & CEO, Dr. Robert Melamede Ph.D., discussing the Company's strategies with its FDA Drug approval programs, the Company's progress to date with its critical drug release programs, and future planning for subsequent drug releases through additional Federal and State government agencies.
The Food and Drug Administration (FDA) has approved a device that automatically monitors blood glucose levels and delivers insulin when appropriate, for people aged 14 years and older who have type 1 diabetes.
Autism affects 1 in 150 children today, making it more common than childhood cancer, juvenile diabetes and pediatric AIDS combined. Despite its widespread effect, autism is not well understood and there are no objective medical tests to diagnose it. Recently, University of Missouri researchers have developed a pupil response test that is 92.5 percent accurate in separating children with autism from those with typical development. In the study, MU scientists found that children with autism have slower pupil responses to light change.
Tomosynthesis imaging may improve breast cancer detection while reducing recall rates at mammographic screening, say researchers.
› Verified 1 days ago
NPI Number | 1134161466 |
Organization Name | Hcr Inc. |
Address | 701 N Broadway Ave Ada, Oklahoma, 74820 |
Phone Number | (580)332-8009 |
News Archive
Cannabis Science Inc. (NASD OTCBB: CBIS) an emerging pharmaceutical cannabis company, is pleased to report that it will be featured on two broadcast radio shows beginning tomorrow with Stu Taylor and the "Equity Strategies Show". Mr. Taylor will interview Cannabis Science Inc., President & CEO, Dr. Robert Melamede Ph.D., discussing the Company's strategies with its FDA Drug approval programs, the Company's progress to date with its critical drug release programs, and future planning for subsequent drug releases through additional Federal and State government agencies.
The Food and Drug Administration (FDA) has approved a device that automatically monitors blood glucose levels and delivers insulin when appropriate, for people aged 14 years and older who have type 1 diabetes.
Autism affects 1 in 150 children today, making it more common than childhood cancer, juvenile diabetes and pediatric AIDS combined. Despite its widespread effect, autism is not well understood and there are no objective medical tests to diagnose it. Recently, University of Missouri researchers have developed a pupil response test that is 92.5 percent accurate in separating children with autism from those with typical development. In the study, MU scientists found that children with autism have slower pupil responses to light change.
Tomosynthesis imaging may improve breast cancer detection while reducing recall rates at mammographic screening, say researchers.
› Verified 1 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 88.5 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 87.5 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 94.2 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | 30.0 | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 95.2 | 97.3 |
Patients who got timely treatment for shortness of breath | 100.0 | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | 100.0 | 93.3 |
News Archive
Cannabis Science Inc. (NASD OTCBB: CBIS) an emerging pharmaceutical cannabis company, is pleased to report that it will be featured on two broadcast radio shows beginning tomorrow with Stu Taylor and the "Equity Strategies Show". Mr. Taylor will interview Cannabis Science Inc., President & CEO, Dr. Robert Melamede Ph.D., discussing the Company's strategies with its FDA Drug approval programs, the Company's progress to date with its critical drug release programs, and future planning for subsequent drug releases through additional Federal and State government agencies.
The Food and Drug Administration (FDA) has approved a device that automatically monitors blood glucose levels and delivers insulin when appropriate, for people aged 14 years and older who have type 1 diabetes.
Autism affects 1 in 150 children today, making it more common than childhood cancer, juvenile diabetes and pediatric AIDS combined. Despite its widespread effect, autism is not well understood and there are no objective medical tests to diagnose it. Recently, University of Missouri researchers have developed a pupil response test that is 92.5 percent accurate in separating children with autism from those with typical development. In the study, MU scientists found that children with autism have slower pupil responses to light change.
Tomosynthesis imaging may improve breast cancer detection while reducing recall rates at mammographic screening, say researchers.
› Verified 1 days ago
Home Health Aides | 7 |
Counselors | 1 |
Licensed Practical or Vocational Nurses | 3 |
Medical Social Workers | 1 |
Physicians | 3 |
Registered Nurses | 4 |
Other Personnel | 1 |
Total Employees | 20 |
---|
News Archive
Cannabis Science Inc. (NASD OTCBB: CBIS) an emerging pharmaceutical cannabis company, is pleased to report that it will be featured on two broadcast radio shows beginning tomorrow with Stu Taylor and the "Equity Strategies Show". Mr. Taylor will interview Cannabis Science Inc., President & CEO, Dr. Robert Melamede Ph.D., discussing the Company's strategies with its FDA Drug approval programs, the Company's progress to date with its critical drug release programs, and future planning for subsequent drug releases through additional Federal and State government agencies.
The Food and Drug Administration (FDA) has approved a device that automatically monitors blood glucose levels and delivers insulin when appropriate, for people aged 14 years and older who have type 1 diabetes.
Autism affects 1 in 150 children today, making it more common than childhood cancer, juvenile diabetes and pediatric AIDS combined. Despite its widespread effect, autism is not well understood and there are no objective medical tests to diagnose it. Recently, University of Missouri researchers have developed a pupil response test that is 92.5 percent accurate in separating children with autism from those with typical development. In the study, MU scientists found that children with autism have slower pupil responses to light change.
Tomosynthesis imaging may improve breast cancer detection while reducing recall rates at mammographic screening, say researchers.
› Verified 1 days ago
Aspire Hospice I Location: 124 East Main, Ada, Oklahoma, 74820 Phone: (580) 332-8009 |
Mccortney Family Hospice, Inc Location: 117 S Broadway, Ada, Oklahoma, 74820 Phone: (580) 332-8009 |
Halo Hospice Location: 314 East Main, Ada, Oklahoma, 74820 Phone: (580) 332-8009 |